Floatz logo

Therapeutic Asset Ratings

4,361 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Alisertib
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2BB (69)
Bendamustine
Burkitt Lymphoma
National Cancer Institute (NCI)P2BB (69)
Cediranib
Estrogen Receptor Negative
National Cancer Institute (NCI)P2BB (69)
Mesna
Disease Related To Hematopoietic Stem Cell Transplant
National Cancer Institute (NCI)P2BB (69)
Ziv-Aflibercept
Ovarian Carcinoma
National Cancer Institute (NCI)P2BB (69)
Cyclophosphamide
Subcutaneous Panniculitis-Like T-Cell Lymphoma
National Cancer Institute (NCI)P4BB (68)
Calcium folinate pentahydrate
Primary Peritoneal Cavity Cancer
National Cancer Institute (NCI)P3BB (68)
Carboplatin
Primary Peritoneal Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P3BB (68)
Cediranib
Adult Acute Basophilic Leukemia
National Cancer Institute (NCI)P3BB (68)
Daunorubicin
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
National Cancer Institute (NCI)P3BB (68)
Daunorubicin
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (68)
Durvalumab
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P3BB (68)
Eloxatin
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P3BB (68)
ERIBULIN MONOMETHANESULFONATE
Metastatic Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)P3BB (68)
ETOPOSIDE
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (68)
FLUOROURACILUM
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P3BB (68)
Glofitamab
Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)P3BB (68)
gsk1120212
Stage IIIC Cutaneous Melanoma AJCC v7
National Cancer Institute (NCI)P3BB (68)
Hycamtin
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)P3BB (68)
Inno-206
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (68)
MERCAPTOPURINE ANHYDROUS
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (68)
MERCAPTOPURINE ANHYDROUS
Down Syndrome
National Cancer Institute (NCI)P3BB (68)
Nivolumab
Renal Pelvis Urothelial Carcinoma
National Cancer Institute (NCI)P3BB (68)
Obinutuzumab
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (68)
Octreotide Pamoate
Digestive System Neuroendocrine Tumor, Grade 1/2
National Cancer Institute (NCI)P3BB (68)
Showing 176 to 200 of 4,361 assets
PreviousPage 8 of 175Next